![Michelle Seltenrich](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michelle Seltenrich
Corporate Officer/Principal bij
RAKOVINA THERAPEUTICS INC.
Vermogen: 5 908 $ op 31-08-2026
Profiel
Michelle Seltenrich is currently Vice President-Operations at Rakovina Therapeutics, Inc., a position starting in 2026.
Formerly, Ms. Seltenrich was Vice President-Operations at Sirona Biochem Corp.
from 2014 to 2023 and Manager-Business Development at Forbes Medi-Tech, Inc. from 2004 to 2008.
Education includes an undergraduate degree from the University of British Columbia in 1996 and an MBA from Simon Fraser University in 2008.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 16-09-2026 | 43.438 ( 0,21% ) | 5 908 $ | 31-08-2026 |
Actieve functies van Michelle Seltenrich
| Bedrijven | Functie | Begin |
|---|---|---|
| RAKOVINA THERAPEUTICS INC. | Corporate Officer/Principal | 01-10-2024 |
Eerdere bekende functies van Michelle Seltenrich
| Bedrijven | Functie | Einde |
|---|---|---|
| SIRONA BIOCHEM CORP. | Operationeel Directeur | 01-08-2023 |
Forbes Medi-Tech, Inc.
 Forbes Medi-Tech, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets nutraceutical products | Corporate Officer/Principal | 01-05-2008 |
Opleiding van Michelle Seltenrich
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
91
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Forbes Medi-Tech, Inc.
Forbes Medi-Tech, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets nutraceutical products | Health Technology |
Sirona Biochem Corp.
 Sirona Biochem Corp. Pharmaceuticals: MajorHealth Technology Develops cosmetic and pharmaceutical active ingredients | Health Technology |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Simon Fraser University
 Simon Fraser University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rakovina Therapeutics, Inc.
 Rakovina Therapeutics, Inc. Financial ConglomeratesFinance Develops oncology therapeutics | Finance |
